Today (10/20) AmacaThera was granted approval from Health Canada to send their post-operative long-term anesthetic into phase one of clinical trials. This is the first drug they have sent through the clinical trial phase a milestone for the company. AmacaThera was funded by Lumira Ventures, Sprout Bioventures, and Grey Sky Venture Partners, early stage investment funding parteners in the field.

Read more here.

More on: